Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis

OBJECTIVES: Our objective was to compare the cardiovascular safety of tocilizumab and other biological disease-modifying antirheumatic drugs (bDMARD) in rheumatoid arthritis using a network meta-analysis (NMA). METHODS: A systematic literature search through May 2018 identified randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagné, Benjamin, Viprey, Marie, Martin, Julie, Schott, Anne-Marie, Cucherat, Michel, Soubrier, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675055/
https://www.ncbi.nlm.nih.gov/pubmed/31369575
http://dx.doi.org/10.1371/journal.pone.0220178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675055/
https://www.ncbi.nlm.nih.gov/pubmed/31369575
http://dx.doi.org/10.1371/journal.pone.0220178

Ejemplares similares